Residual and recurrent disease after laser conization for cervical intraepithelial neoplasia

Obstetrics and Gynecology

Volumn 90, Issue 3, 1997, Pages 428-433

  Skjeldestad, F E ^a   Hagen, B ^a   Lie, A K ^a   Isaksen, C ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; DISEASE CONTROL; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PREDICTION; PRIORITY JOURNAL; RESIDUE ANALYSIS; RISK ASSESSMENT; SURVIVAL RATE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LASER SURGERY; LOGISTIC MODELS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; UTERINE CERVICAL NEOPLASMS;

EID: 0030850060     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00276-7     Document Type: Article

References (23)

1. Bjørge T, Thoresen SØ, Gunbjørud AB. Masseundersøkelsen mot livmorhalskreft Nå starter invitasjonene til kvinner på landsbasis [Norwegian] . Tidsskr Nor Lægeforen. 115:1995;815-816.
2. Haugen OA. Forbruk av vaginalcytologiske prøver i Norge [Norwegian]. Tidsskr Nor Lægeforen. 104:1984;952-956.
3. Forsmo S, Buhaug H, Stalsberg H. Use of Papanicolaou smears in a population without a mass screening program. Acta Obstet Gynecol Scand. 73:1994;824-828.
4. Bjørge T, Gunbjørud AB, Langmark F, Skare GB, Thoresen SØ. Cervical mass screening in Norway - 510,000 smears a year. Cancer Detect Prev. 6:1994;463-470.
5. Forsmo S, Buhaug H, Skjeldestad FE, Haugen OA. Treatment of preinvasive conditions during opportunistic screening and its effectiveness on the cervical cancer incidence in one Norwegian county. Int J Cancer. 71:1997;4-8.
6. Screening for squamous cervical cancer Duration of low risk after negative results of cervical cytology and its implication for screening policies . BMJ. 293:1986;659-664.
7. Sigurdsson K. Effect of organized screening on the risk of cervical cancer Evaluation of screening activity in Iceland, 1964-91 . Int J Cancer. 54:1993;563-570.
8. Scheistrøen M. Laserbehandling av premaligne sykdommer i cervix uteri [Norwegian]. Tidsskr Nor Lægeforen. 112:1992;1145-1147.
9. Forsmo S, Øian P, Stalsberg H. Cervikal intraepitelial neoplasi Persistens og residiv etter laserbehandling [Norwegian] . Tidsskr Nor Lægeforen. 112:1992;1148-1151.
10. Tabor A, Berget A. Cold-knife and laser conization for cervical intraepithelial neoplasia. Obstet Gynecol. 76:1990;633-635.
11. Andersen ES, Pedersen B, Nielsen K. Laser conization The results of treatment of cervical intraepithelial neoplasia . Gynecol Oncol. 54:1994;201-204.
12. Sigurdsson K. Quality assurance in cervical cancer screening The Icelandic experience 1964-1993 . Eur J Cancer. 31A:1995;728-734.
13. Rylander E, Isberg A, Joelson I. Laser vaporization of cervical intraepithelial neoplasia. A five-year follow-up. Acta Obstet Gynecol Scand Suppl 1984;125:33-6.
14. Dorsey JH, Diggs ES. Microsurgical conization of the cervix by carbon dioxide laser. Obstet Gynecol. 54:1979;565-570.
15. Lopez A, Morgan P, Murdoch J, Piura B, Monaghan JM. The case of conservative management of "incomplete excision" of CIN after laser conization. Gynecol Oncol. 49:1993;247-249.
16. Kolstad P, Klem V. Long-term follow-up of 1121 cases of carcinoma in situ. Obstet Gynecol. 48:1976;125-129.
17. Vedel P, Jakobsen H, Kryger-Baggesen N, Rank F, Bostofte E. Five-year follow up of patients with cervical intraepithelial neoplasia in the cone margins after conization. Eur J Obstet Gynecol Reprod Biol. 50:1993;71-76.
18. Nøstdahl W. Cytologiske kontroller etter behandling av premaligne lidelser i cervix uteri [Norwegian]. Tidsskr Nor Lægeforen. 113:1993;1884-1885.
19. Gustafsson L, Adami H-O. Natural history of cervical neoplasia Consistent results obtained by an identification technique . Br J Cancer. 60:1989;132-141.
20. Van Oortmarssen GJ, Habbema JDF. Duration of preclinical cervical cancer and reduction in incidence of invasive negative Pap smears. Int J Epidemiol. 24:1995;300-307.
21. Albert A. Estimated cervical cancer disease state incidence and transition rates. J Natl Cancer Inst. 67:1981;571-576.
22. Prorok PC. Mathematical models and natural history in cervical cancer screening. Hakama M, Miller AB, Day NE. Screening for cancer of the uterine cervix. 1986;185-196 International Union Against Cancer, Lyon.
23. Eddy DM. The frequency of cervical cancer screening Comparison of a mathematical model with empirical data . Cancer. 60:1987;1117-1122.